Although previous studies suggested that the expression of FMS-like tyrosine kinase 3 (Flt3) initiates downstream of mouse hematopoietic stem cells (HSCs), FLT3 internal tandem duplications (FLT3 ITDs) have recently been suggested to intrinsically suppress HSCs. Herein, single-cell interrogation found Flt3 mRNA expression to be absent in the large majority of phenotypic HSCs, with a strong negative correlation between Flt3 and HSC-associated gene expression. Flt3-ITD knock-in mice showed reduced numbers of phenotypic HSCs, with an even more severe loss of long-term repopulating HSCs, likely reflecting the presence of non-HSCs within the phenotypic HSC compartment. Competitive transplantation experiments established that Flt3-ITD compromises HSCs through an extrinsically mediated mechanism of disrupting HSC-supporting bone marrow stromal cells, with reduced numbers of endothelial and mesenchymal stromal cells showing increased inflammation-associated gene expression. Tumor necrosis factor (TNF), a cell-extrinsic potent negative regulator of HSCs, was overexpressed in bone marrow niche cells from FLT3-ITD mice, and anti-TNF treatment partially rescued the HSC phenotype. These findings, which establish that Flt3-ITD-driven myeloproliferation results in cell-extrinsic suppression of the normal HSC reservoir, are of relevance for several aspects of acute myeloid leukemia biology.
J Exp Med
2005 - 2021
Animals, Anti-Inflammatory Agents, Non-Steroidal, Bone Marrow Cells, Bone Marrow Transplantation, Cell Proliferation, Cells, Cultured, Etanercept, Gene Expression Profiling, Hematopoietic Stem Cells, Mesenchymal Stem Cells, Mice, Inbred C57BL, Mice, Transgenic, Mutation, Reverse Transcriptase Polymerase Chain Reaction, Single-Cell Analysis, Stem Cell Niche, Tandem Repeat Sequences, Tumor Necrosis Factor-alpha, fms-Like Tyrosine Kinase 3